Detalhe do blog
Kuehne+Nagel expande logística de cadeia fria farmacêutica em Hyderabad
What Happened
Kuehne+Nagel has expanded its healthcare logistics network in India with a new temperature-controlled airfreight cross-dock facility in Hyderabad. The facility is designed to support pharmaceutical and medical shipments that require safe handling, regulatory consistency, and reliable temperature control during airfreight transfer.
Hyderabad is a strategic location for this investment. The city is one of India’s major pharmaceutical manufacturing centers and contributes more than 40% of the country’s active pharmaceutical ingredients and vaccine production. For global healthcare supply chains, this makes Hyderabad an important origin point for temperature-sensitive products moving into international markets.
Como funciona
The new facility covers 248 square meters and operates across dedicated temperature zones, including +2°C to +8°C and +15°C to +25°C. These controlled environments are used to protect healthcare shipments that may be sensitive to temperature variation during storage, manuseio, and transport handover.
The site also follows Kuehne+Nagel’s global HealthChain quality standard, supporting GxP-aligned processes across healthcare logistics. With the Hyderabad opening, Kuehne+Nagel now operates two HealthChain-certified facilities in India, following the launch of its Bengaluru Cool Zone facility in December 2025.
Por que isso importa
Pharma cold chain logistics is becoming more infrastructure-driven. Para vacinas, Biologics, APIs, e medicamentos especiais, temperature-controlled packaging alone is not enough. Shippers also need compliant facilities, validated handling processes, and reliable transfer points near manufacturing hubs.
The Hyderabad facility helps reduce risk at a critical stage of the shipment journey. Airfreight cross-dock operations often involve product handover, retenção temporária, documentation checks, and transfer between logistics partners. Dedicated temperature zones can help protect product integrity during these transitions.
B2B Impact
Para fabricantes farmacêuticos, this expansion improves access to specialized healthcare logistics capacity in one of India’s most important pharma hubs. It may support faster export handling, more consistent product protection, and stronger confidence in compliant distribution.
Para embalagens de cadeia fria, monitoramento, and validation providers, the development also signals continued demand for integrated pharma logistics solutions in India. As more healthcare logistics sites adopt certified temperature-controlled operations, suppliers of validated shippers, madeireiros de temperatura, embalagem térmica, and lane qualification services may find new business opportunities.
The broader message is clear: pharma cold chain buyers are looking for complete logistics ecosystems. Instalações, embalagem, monitoramento, conformidade, and documentation are becoming part of one connected value chain.
